Absence of micronucleus formation in CHO-K1 cells cultivated in platelet lysate enriched medium

Martina Bernardi1, Valentina Adami2, Elena Albiero1

  • 1Hematology Project Foundation Research Laboratories, Contrà S. Francesco 41, Vicenza, Italy; Advanced Cellular Therapy Laboratory, Department of Cellular Therapy and Hematology, San Bortolo Hospital, Via Rodolfi 37, Vicenza, Italy.

Insights

Human platelet lysate (PL) enhances mesenchymal stromal cell (MSC) proliferation without inducing significant chromosomal instability. This study used high content screening (HCS) to assess PL safety for cell-based therapies.

Area of Science:

  • Cell Biology
  • Biotechnology
  • Toxicology

Background:

  • Human platelet lysate (PL) is a superior alternative to fetal bovine serum (FBS) for culturing mesenchymal stromal cells (MSCs).
  • PL promotes MSC proliferation and reduces risks associated with animal-derived products.
  • Platelet disruption methods, like sonication, release growth factors but may also generate free radicals.

Purpose of the Study:

  • To evaluate if PL-induced MSC proliferation causes mitotic stress.
  • To determine if PL production via ultrasound leads to chromosomal instability in mammalian cells.
  • To assess the safety of PL as a component in cell-based medicinal products.

Main Methods:

  • An in vitro micronucleus assay was performed on Chinese Hamster Ovarian K1 (CHO-K1) cells.
  • PL was produced using sonication and cells were exposed to varying PL concentrations.
  • High content screening (HCS) with automated image analysis was employed to detect micronucleus formation.

Main Results:

  • PL-stimulated growth did not significantly increase micronucleus formation in CHO-K1 cells compared to controls.
  • The use of PL did not appear to induce significant chromosomal instability.
  • HCS-based micronucleus testing proved effective for evaluating ancillary material safety.

Conclusions:

  • PL is a safe alternative to FBS for MSC cultivation, showing no significant genotoxicity.
  • High content screening micronucleus assay is a valuable tool for assessing the safety of materials used in cell therapy production.
  • Further research can validate PL's role in regenerative medicine manufacturing.

Related Concept Videos